Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2

doi:10.1111/ajt.16726

Comment

. 2021 Nov;21(11):3806-3807.

doi: 10.1111/ajt.16726. Epub 2021 Jul 10.

Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2

Louis Firket¹, Julie Descy², Laurence Seidel³, Catherine Bonvoisin¹, Antoine Bouquegneau¹, Stéphanie Grosch¹, François Jouret^{1

4}, Laurent Weekers¹

Affiliations

¹ Division of Nephrology, University of Liege Hospital (ULiege CHU), Liege, Belgium.
² Division of Microbiology, University of Liege Hospital (ULiege CHU), Liege, Belgium.
³ Division of Biostatistics, University of Liege Hospital (ULiege CHU), Liege, Belgium.
⁴ Laboratory of Translational Research in Nephrology, University of Liege GIGA Research Center, ULiege, Liege, Belgium.

PMID: 34153162
PMCID: PMC8441800
DOI: 10.1111/ajt.16726

Comment

Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2

Louis Firket et al. Am J Transplant. 2021 Nov.

. 2021 Nov;21(11):3806-3807.

doi: 10.1111/ajt.16726. Epub 2021 Jul 10.

Authors

Louis Firket¹, Julie Descy², Laurence Seidel³, Catherine Bonvoisin¹, Antoine Bouquegneau¹, Stéphanie Grosch¹, François Jouret^{1

4}, Laurent Weekers¹

Affiliations

¹ Division of Nephrology, University of Liege Hospital (ULiege CHU), Liege, Belgium.
² Division of Microbiology, University of Liege Hospital (ULiege CHU), Liege, Belgium.
³ Division of Biostatistics, University of Liege Hospital (ULiege CHU), Liege, Belgium.
⁴ Laboratory of Translational Research in Nephrology, University of Liege GIGA Research Center, ULiege, Liege, Belgium.

PMID: 34153162
PMCID: PMC8441800
DOI: 10.1111/ajt.16726

No abstract available

Keywords: clinical research/practice; immunosuppressant; immunosuppression/immune modulation; infection and infectious agents - viral; infectious disease; kidney transplantation/nephrology; vaccine.

PubMed Disclaimer

Comment on

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.
Grupper A, Rabinowich L, Schwartz D, Schwartz IF, Ben-Yehoyada M, Shashar M, Katchman E, Halperin T, Turner D, Goykhman Y, Shibolet O, Levy S, Houri I, Baruch R, Katchman H. Grupper A, et al. Am J Transplant. 2021 Aug;21(8):2719-2726. doi: 10.1111/ajt.16615. Epub 2021 May 7. Am J Transplant. 2021. PMID: 33866672 Free PMC article.

Cited by

Humoral and cellular immune response to severe acute respiratory syndrome coronavirus-2 vaccination in haemodialysis and kidney transplant patients.
Swai J, Gui M, Long M, Wei Z, Hu Z, Liu S. Swai J, et al. Nephrology (Carlton). 2022 Jan;27(1):7-24. doi: 10.1111/nep.13974. Epub 2021 Sep 27. Nephrology (Carlton). 2022. PMID: 34510645 Free PMC article. Review.
Hybrid Immunity Provides the Best COVID-19 Humoral Response in Immunocompromised Patients with or without SARS-CoV-2 Infection History.
Nazaruk P, Tkaczyk I, Monticolo M, Jędrzejczak AM, Krata N, Pączek L, Foroncewicz B, Mucha K. Nazaruk P, et al. Vaccines (Basel). 2023 Aug 18;11(8):1380. doi: 10.3390/vaccines11081380. Vaccines (Basel). 2023. PMID: 37631947 Free PMC article.
Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients.
Tylicki L, Dębska-Ślizień A, Muchlado M, Ślizień Z, Gołębiewska J, Dąbrowska M, Biedunkiewicz B. Tylicki L, et al. Vaccines (Basel). 2021 Dec 31;10(1):56. doi: 10.3390/vaccines10010056. Vaccines (Basel). 2021. PMID: 35062717 Free PMC article.
The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review.
Hou YC, Lu KC, Kuo KL. Hou YC, et al. Vaccines (Basel). 2021 Aug 10;9(8):885. doi: 10.3390/vaccines9080885. Vaccines (Basel). 2021. PMID: 34452010 Free PMC article. Review.
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review.
Galmiche S, Luong Nguyen LB, Tartour E, de Lamballerie X, Wittkop L, Loubet P, Launay O. Galmiche S, et al. Clin Microbiol Infect. 2022 Feb;28(2):163-177. doi: 10.1016/j.cmi.2021.09.036. Epub 2021 Nov 17. Clin Microbiol Infect. 2022. PMID: 35020589 Free PMC article.

See all "Cited by" articles

References

1. Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus [published online ahead of print April 18, 2021]. Am J Transplant. 2021. 10.1111/ajt.16615 - DOI - PMC - PubMed
1. Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients [published online ahead of print May 5, 2021] JAMA. 2021;325(21):2204. doi: 10.1001/jama.2021.7489. - DOI - PMC - PubMed
1. Benotmane I, Gautier-Vargas G, Cognard N, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine [published online ahead of print April 20, 2021] Kidney Int. 2021;99(6):1498–1500. S0085-2538[21]00389-6. - PMC - PubMed
1. Cucchiari D, Egri N, Bodro M, et al. Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients [published online ahead of print May 26, 2021]. Am J Transplant. 2021. Am J Transplant. 2021. 10.1111/ajt.16701 - DOI - PMC - PubMed
1. World Health Organization. Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-f.... Updated May 12, 2021. Accessed June 9, 2021.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus [published online ahead of print April 18, 2021]. Am J Transplant. 2021. 10.1111/ajt.16615 - DOI - PMC - PubMed

[2] Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus [published online ahead of print April 18, 2021]. Am J Transplant. 2021. 10.1111/ajt.16615 - DOI - PMC - PubMed

[3] Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients [published online ahead of print May 5, 2021] JAMA. 2021;325(21):2204. doi: 10.1001/jama.2021.7489. - DOI - PMC - PubMed

[4] Boyarsky BJ, Werbel WA, Avery RK, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients [published online ahead of print May 5, 2021] JAMA. 2021;325(21):2204. doi: 10.1001/jama.2021.7489. - DOI - PMC - PubMed

[5] Benotmane I, Gautier-Vargas G, Cognard N, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine [published online ahead of print April 20, 2021] Kidney Int. 2021;99(6):1498–1500. S0085-2538[21]00389-6. - PMC - PubMed

[6] Benotmane I, Gautier-Vargas G, Cognard N, et al. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine [published online ahead of print April 20, 2021] Kidney Int. 2021;99(6):1498–1500. S0085-2538[21]00389-6. - PMC - PubMed

[7] Cucchiari D, Egri N, Bodro M, et al. Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients [published online ahead of print May 26, 2021]. Am J Transplant. 2021. Am J Transplant. 2021. 10.1111/ajt.16701 - DOI - PMC - PubMed

[8] Cucchiari D, Egri N, Bodro M, et al. Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients [published online ahead of print May 26, 2021]. Am J Transplant. 2021. Am J Transplant. 2021. 10.1111/ajt.16701 - DOI - PMC - PubMed

[9] World Health Organization. Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-f.... Updated May 12, 2021. Accessed June 9, 2021.

[10] World Health Organization. Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-f.... Updated May 12, 2021. Accessed June 9, 2021.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2

Affiliations

Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous